DTIL Precision BioSciences, Inc.
Precision BioSciences, Inc. (DTIL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: September 28, 2026 , by Frankel Stanley .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Frankel Stanley | Director | Buy | 1,000 | $6.00 | $6.0K | 41,478 | |
| Germano Geno J | Director | Buy | 2,609 | $6.28 | $16.4K | 47,492 | |
| Brown Melinda | Director | Buy | 1,135 | $6.27 | $7.1K | 45,481 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.